References
Castelli R, Gallipoli P, Schiavon R, Teatini T, Deliliers GL, Bergamaschini L (2018) High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation. J Thromb Thrombolysis 45(1):106–113. https://doi.org/10.1007/s11239-017-1566-1
Antonioli E, Guglielmelli P, Poli G et al (2008) Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia. Haematologica 93(1):41–48. https://doi.org/10.3324/haematol.11653
Vannucchi AM, Antonioli E, Guglielmelli P et al (2007) Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 110(3):840–846. https://doi.org/10.1182/blood-2006-12-064287
Colombo R, Gallipoli P, Castelli R (2014) Thrombosis and hemostatic abnormalities in hematological malignancies. Clin Lymphoma Myeloma Leuk 14(6):441–450
Castelli R, Ferrari B, Cortelezzi A, Guariglia A (2010) Thromboembolic complications in malignant haematological disorders. Curr Vasc Pharmacol 4:482–494
De Stefano V, Za T, Rossi E et al (2010) Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation. Ann Hematol 89(2):141–146. https://doi.org/10.1007/s00277-009-0788-5
De Stefano V, Za T, Rossi E et al (2009) Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia. Haematologica 94(5):733–737. https://doi.org/10.3324/haematol.13869
Takahaski K, Patel P (2013) V617F detection and allele burden measurement in peripheral blood and bone marrow aspirate in patients with myeloproliferative neoplasms. Blood 122(23):3784–3786
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Castelli, R., Gallipoli, P., Schiavon, R. et al. Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation. J Thromb Thrombolysis 47, 155–156 (2019). https://doi.org/10.1007/s11239-018-1773-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-018-1773-4